$316.50
38.11[13.69%]
At close: May 3
$316.50
0[0.00%]
PreMarket: 5:49AM EDT
Latest News for Amgen Stock (NASDAQ:AMGN)
Amgen Stock (NASDAQ: AMGN)
Categories: All
Friday, May 03, 2024
Thursday, May 02, 2024
- Apple, Coinbase, Block, Amgen, Tesla: Why These 5 Stocks Are On Investors' Radars TodayBenzinga Neuro - 7 hours ago
- Amgen Reports Better-Than-Expected Q1 Results, $50M Milestone PaymentErica Kollmann - 12 hours ago
- Amgen shares are trading higher after the company reported better-than-expected Q1 financial results. Also, the company announced a $50 million milestone payment from Royalty Pharma.Benzinga Newsdesk - 13 hours ago
- Arrowhead Pharmaceuticals Earns $50M Milestone From Royalty Pharma, Pursuant To Its 2016 Agreement With Amgen And 2022 Agreement With Royalty Pharma, Arrowhead Is Further Eligible To Receive Up To An Additional $375M From Amgen And $110M From Royalty Pharma In Aggregate Development, Regulatory, And Sales Milestone Payments Associated With OlpasiranBenzinga Newsdesk - 13 hours ago
- Amgen Sees FY24 Adj. EPS $ 19.00-$20.20 vs $19.48 Est.Benzinga Newsdesk - 14 hours ago
- Amgen Q1 2024 Adj EPS $3.96 Beats $3.87 Estimate, Sales $7.447B Beat $7.436B EstimateBenzinga Newsdesk - 14 hours ago
- Wall Street Inches Up After Powell's Inflation Remarks; Chipmakers Rebound; Gold, Crude Falter: What's Driving Markets Thursday?Piero Cingari - 16 hours ago
- Amgen's Options: A Look at What the Big Money is ThinkingBenzinga Insights - 16 hours ago
- Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For MarketShanthi Rexaline - 23 hours ago
Wednesday, May 01, 2024
Tuesday, April 30, 2024
Monday, April 29, 2024
Friday, April 26, 2024
Wednesday, April 24, 2024
Friday, April 19, 2024
Wednesday, April 17, 2024
- Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His PickVandana Singh - Apr 17, 2024, 2:39PM
- Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For WednesdayAvi Kapoor - Apr 17, 2024, 8:21AM
- TD Cowen Maintains Buy on Amgen, Lowers Price Target to $360Benzinga Newsdesk - Apr 17, 2024, 6:04AM
Monday, April 15, 2024
Friday, April 12, 2024
Wednesday, April 03, 2024
Tuesday, April 02, 2024
Monday, April 01, 2024
Thursday, March 28, 2024
Monday, March 18, 2024
Thursday, March 14, 2024
Wednesday, March 13, 2024
Friday, March 08, 2024
Thursday, March 07, 2024
Wednesday, March 06, 2024
Friday, March 01, 2024
Monday, February 26, 2024
Friday, February 23, 2024
Tuesday, February 20, 2024
Thursday, February 15, 2024
Monday, February 12, 2024
Thursday, February 08, 2024
Wednesday, February 07, 2024
- Investors' Focus Around Amgen's Obesity Drug Data Shadows Better Than Expected Q4 EarningsVandana Singh - Feb 7, 2024, 2:36PM
- S&P 500 Flirts With 5,000 As Magnificent 7 Tops $13 Trillion, NYCB Sinks: What's Driving Markets Wednesday?Piero Cingari - Feb 7, 2024, 1:40PM
- RBC Capital Maintains Outperform on Amgen, Raises Price Target to $329Benzinga Newsdesk - Feb 7, 2024, 11:50AM